Adagio Medical Holdings, Inc.ADGMNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank40
3Y CAGR-12.8%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-12.8%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$11.82M+155.1%
2024$4.63M-69.9%
2023$15.40M-13.8%
2022$17.86M+16.3%
2021$15.36M-
2020$0.00-